Search results for "biopharm" in Articles / App Notes
Article
Maximum Output Starts with Optimized Upstream Processing
Challener
Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity.
Significant growth in the development and manufa…
Article
Single-Use Technologies Prove Effective for Viral Vector Process Development
Challener, PhD, is a contributing editor to BioPharm International.
Editor's Note
This is an expanded version of the article published in the August 2021 issue of BioPharm International.
Article
Improving Upstream Predictability
Currently, he says, 50–60% of biopharmaceutical developers and manufacturers have either implemented or are considering use of perfusion for seed train or production bioreactor steps. Used with high c…
Article
Biosimilar Quality Requirements
Wechsler, BioPharm International 32 (7) 6–7 (2019).
5. M. DiPaola and I. Javeri, BioPharm International 32 (9) 34–38 (2019).
Article
Tools and Processes for Mature and Emerging Therapies
Cytiva also announced a partnership with Rockwell Automation to use augmented reality technology; biopharma companies will be able to monitor production processes, review equipment setup, provide inst…
Article
Single-Use for Downstream Chromatography: Benefit or Hindrance?
Resin fouling
Another unmet need for biopharmaceutical manufacturers is technology that reduces the cost of resins (3), to allow for greater use of single-use systems to address the resin fouling t…
Article
Modeling the Degradation of mAb Therapeutics
This is particularly true for monoclonal antibodies (mAbs), which account for most commercial biopharmaceuticals today. Both physical effects such as aggregation and chemical modifications (e.g., frag…
Article
Biopharma Says It Has an Evolution in New Technologies and Processes
Rita Peters, editorial director of BioPharm International, shares observations of the magazine’s editorial team as they reported on industry developments at the April event.
Q: What insight did F…
Article
ADC Development Robust Despite Lackluster Performance
This has not stopped ADC developers, though, and the biopharmaceutical pipeline is populated with ADC candidates under development.
The promise of conjugation
ADCs are part of a relatively new c…
Article
Advancing Single-Use Technology Through Collaboration
By Cheryl Zigrand
The use of disposable, single-use components within the biopharmaceutical manufacturing process is not a new phenomenon. Silicone tubing, capsule filters, tissue culture flasks, …